These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16451825)

  • 21. Harmonic gray scale 3D contrast imaging of the liver.
    Moriyasu F; Migihashi R; Matsumura T; Toda Y; Chiba T
    Acad Radiol; 2002 May; 9 Suppl 1():S228-30. PubMed ID: 12019876
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis].
    Rickes S; Ocran K; Schulze S; Wermke W
    Ultraschall Med; 2002 Apr; 23(2):83-90. PubMed ID: 11961720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enhanced color flow findings in small hepatocellular carcinoma].
    Maruyama H; Matsutani S; Ebara M; Saisho H
    Nihon Rinsho; 1998 Apr; 56(4):967-74. PubMed ID: 9577618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Imaging diagnosis of hepatocellular carcinoma: recent progress].
    Kudo M
    Nihon Shokakibyo Gakkai Zasshi; 2001 Jul; 98(7):795-808. PubMed ID: 11510081
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnostic usefulness of color Doppler US to hepatocellular carcinoma].
    Takahashi M; Hirai T; Tokuno E; Matsumoto A; Hirohashi S; Kichikawa K; Ohishi H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():254-7. PubMed ID: 11761950
    [No Abstract]   [Full Text] [Related]  

  • 27. Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Morimoto M; Shirato K; Sugimori K; Kokawa A; Tomita N; Saito T; Imada T; Tanaka N; Nozawa A; Numata K; Tanaka K
    AJR Am J Roentgenol; 2003 Jul; 181(1):65-9. PubMed ID: 12818831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma: Advances in diagnostic imaging.
    Sun H; Song T
    Drug Discov Ther; 2015 Oct; 9(5):310-8. PubMed ID: 26632539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Liver imagenology advances].
    Stoopen ME
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():37-40. PubMed ID: 17471855
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
    Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional power Doppler ultrasonography for hepatocellular carcinoma: a comparison with angiography?
    Sato S; Yoshida H; Teratani T; Obi S; Koike Y; Shiina S; Omata M
    Hepatogastroenterology; 2005; 52(61):72-5. PubMed ID: 15782997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma: evaluation with color Doppler US and MR imaging.
    Shimamoto K; Sakuma S; Ishigaki T; Ishiguchi T; Itoh S; Fukatsu H
    Radiology; 1992 Jan; 182(1):149-53. PubMed ID: 1309215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of ultrasound and doppler sonography in chronic hepatitis and liver cirrhosis].
    Vogt W
    Praxis (Bern 1994); 2005 Apr; 94(16):639-43. PubMed ID: 15900827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasonography, computed tomography and magnetic resonance imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Imai Y; Okada M; Hyodo T; Lee WJ; Kim MJ; Kim T; Choi BI
    Oncology; 2011; 81 Suppl 1():86-99. PubMed ID: 22212941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous ablation therapy guided by contrast-enhanced sonography for patients with hepatocellular carcinoma.
    Numata K; Isozaki T; Ozawa Y; Sakaguchi T; Kiba T; Kubota T; Ito A; Sugimori K; Shirato K; Morimoto M; Tanaka K
    AJR Am J Roentgenol; 2003 Jan; 180(1):143-9. PubMed ID: 12490493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
    Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
    Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoblastoma.
    Novick DM; DeLuca SA
    Am Fam Physician; 1986 Feb; 33(2):141-2. PubMed ID: 3004183
    [No Abstract]   [Full Text] [Related]  

  • 39. Ultrasonic features and radionuclide correlation in liver cell adenoma and focal nodular hyperlasia.
    Sandler MA; Petrocelli RD; Marks DS; Lopez R
    Radiology; 1980 May; 135(2):393-7. PubMed ID: 6245428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatocellular carcinoma: Role of imaging diagnostics in detection, intervention and follow-up].
    Vogl TJ; Eichler K; Zangos S; Mack M; Hammerstingl R
    Rofo; 2002 Nov; 174(11):1358-68. PubMed ID: 12424661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.